The National Animal Supplement Council has proposed a federal Animal Health Supplement Act to resolve long-standing regulatory ambiguity over non-drug supplements for animals in the United States.

The trade association, representing manufacturers of supplements marketed for joint health, skin and coat, digestive function, and behavior in companion animals and other non-food-producing species, outlined the proposal as reported by PetfoodIndustry. The legislation would create a defined federal category for products that currently sit between conventional animal food and regulated drugs.

What regulatory gap does the act target?

Supplements for animals fall between two regulated categories under the U.S. Food and Drug Administration. Animal food falls under the FDA Center for Veterinary Medicine, while animal drugs require premarket approval and a substantially higher evidentiary burden. The FDA CVM has historically exercised enforcement discretion over most non-drug health products, declining to treat them as drugs while also declining to write a dedicated regulatory framework for them.

NASC argues that this discretion leaves manufacturers, veterinarians, and pet owners without consistent federal standards for labeling, adverse-event reporting, and quality control. The proposed act would establish a single federal category with its own definitions and compliance expectations, replacing the patchwork of state rules that manufacturers currently manage.

How does the proposal compare to existing frameworks?

Industry observers have pointed to the Dietary Supplement Health and Education Act of 1994 as a structural reference. That statute carved out a separate category for human dietary supplements under the FDA, with distinct labeling, manufacturing, and claim rules that differ from those for human drugs or conventional food. The animal-side proposal seeks comparable statutory clarity, though the available source reporting does not include the draft legislative text.

A federal animal supplement category would resolve longstanding questions about which agency claims primary jurisdiction. The FDA CVM would likely remain the lead regulator, with the U.S. Department of Agriculture continuing to oversee products for food-producing species under its existing authorities.

What changes at the exam table?

For practicing veterinarians, a clear federal standard would mean more uniform labels across products from different manufacturers, including standardized warnings, ingredient declarations, and adverse-event contact information. Companion-animal practitioners would gain a single reference point when discussing supplements with clients, reducing confusion about which products meet which standards.

Food-animal veterinarians would continue to operate under existing FDA CVM and USDA rules for livestock treatments and feed. The act would not change withdrawal-time expectations or prescription requirements for drugs used in production animals. Section takeaway: companion practice gains uniformity; livestock practice stays the same.

What changes for pet owners?

Pet owners could see changes to label formatting and to substantiation required for structure-function claims, though the proposal would not elevate supplements to drug status. Adverse-event reporting would shift from voluntary manufacturer programs to a structured federal channel, generating a clearer picture of post-market safety signals than the current system allows.

The current voluntary Quality Seal program would likely give way to mandatory federal quality requirements. Manufacturers already meeting the seal standard would face lower transition costs than those operating outside it. Section takeaway: owners gain clearer labels and a stronger adverse-event system.

What happens next?

NASC has indicated it will seek legislative sponsors in Congress and continue engagement with veterinary associations, state feed control officials, and member manufacturers. Congress would need to pass the statute in both chambers and the president would need to sign it before the FDA CVM begins formal rulemaking on definitions, labeling, and adverse-event procedures.

The council's existing Quality Seal program, a voluntary certification used by many U.S. animal supplement makers, is expected to continue during the legislative process and could serve as a quality benchmark under any new federal framework. NASC members will watch the early legislative calendar for indications of congressional interest in the coming session.